LYCOS RETRIEVER 
Zyprexa: Schizophrenia
built 656 days ago
Zyprexa is an antipsychotic medication. It works by changing the actions of chemicals in the brain. Zyprexa is used to treat the symptoms of psychotic conditions such as schizophrenia and bipolar disorder. Zyprexa may ... be used for purposes other than those listed on eDrug.org.
Source:
Olanzapine (Zyprexa®) is an antipsychotic medication approved to treat schizophrenia, and acute mania or mixed episodes of bipolar disorder. Olanzapine can improve symptoms of schizophrenia such as: hallucinations, delusions, and disorganized thinking; in some people, improvement in social isolation, reduced speech productivity and motivation. Olanzapine can improve symptoms of mania which include: racing thoughts, having an inflated sense of importance, an elevated mood, being impulsive, being irritable as well as a decreased need for sleep. Olanzapine has ... been approved for the treatment of agitation associated with schizophrenia or bipolar I mania.
Source:
Zyprexa treats schizophrenics and bipolar disorder sufferers by altering their brain chemistry to correct the chemical imbalances responsible for the perpetuation of the mental illness. Schizophrenia and bipolar disorder are believed to be tied to certain imbalances of serotonin and dopamine, two of the brain's neurotransmitters that are responsible for the regulation of emotions and motivations in addition to the activation of nerve impulses.
Source:
Zyprexa is used to treat a wide range of disorders including bipolarism, manic depression, anxiety, schizophrenia and other psychotic conditions. Zyprexa works by inhibiting certain dopamine and serotonin receptors that are believed to be linked to schizophrenia and other psychotic disorders including depression.
Source:
Zyprexa - generic Olanzapine - is called an "atypical antipsychotic" medication. According to the manufacturer, Eli Lilly, it was the first in this group to be approved for the short-term treatment of bipolar mania, where it acts as a mood stabilizer, and for long-term therapy for schizophrenia, where it helps to control hallucinations, delusions, apathy and withdrawal.
Source:
ACADIA is developing ACP-103 as a novel therapy for schizophrenia to be used in combination with currently available antipsychotic drugs including haloperidol, Zyprexa, Risperdal and Seroquel. These antipsychotics cause a variety of unfavorable side effects, including hyperprolactinemia, which can adversely affect menstrual and sexual function, and akathisia, an extremely distressful motor disturbance characterized by feelings of inner restlessness and an urge to move. ACP-103, when combined with existing antipsychotic drugs, may reduce the side effects associated with these drugs and expand their range of efficacy.
Source:
MORE ABOUT
Schizophrenia